Co-Authors
This is a "connection" page, showing publications co-authored by CHADI ABDALLAH and LYNNETTE AVERILL.
Connection Strength
9.603
-
Prefrontal Glutamate Neurotransmission in PTSD: A Novel Approach to Estimate Synaptic Strength in Vivo in Humans. Chronic Stress (Thousand Oaks). 2022 Jan-Dec; 6:24705470221092734.
Score: 0.829
-
Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine. Expert Opin Investig Drugs. 2022 02; 31(2):133-137.
Score: 0.821
-
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression. J Affect Disord. 2022 04 15; 303:91-97.
Score: 0.818
-
Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence. Adv Pharmacol. 2020; 89:163-194.
Score: 0.726
-
Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies. Neurosci Lett. 2017 05 10; 649:147-155.
Score: 0.572
-
Findings of PTSD-specific deficits in default mode network strength following a mild experimental stressor. NPP Digit Psychiatry Neurosci. 2024; 2(1):9.
Score: 0.241
-
The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence. Ther Adv Psychopharmacol. 2023; 13:20451253231154125.
Score: 0.221
-
Biological embedding of early trauma: the role of higher prefrontal synaptic strength. Eur J Psychotraumatol. 2023; 14(2):2246338.
Score: 0.218
-
Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022 Jul; 47(8):1583-1584.
Score: 0.210
-
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022 07; 47(8):1574-1581.
Score: 0.204
-
Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder. Chronic Stress (Thousand Oaks). 2020 Jan-Dec; 4:2470547020984726.
Score: 0.190
-
A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants. Neuropsychopharmacology. 2021 01; 46(2):478-485.
Score: 0.186
-
Early life stress and glutamate neurotransmission in major depressive disorder. Eur Neuropsychopharmacol. 2020 06; 35:71-80.
Score: 0.182
-
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology. 2020 05; 45(6):990-997.
Score: 0.179
-
Of Forests and Trees: Bridging the Gap Between Neurobiology and Behavior in Posttraumatic Stress Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 02; 5(2):135-137.
Score: 0.178
-
A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants. iScience. 2020 Jan 24; 23(1):100800.
Score: 0.177
-
When the "Golden Chain" Breaks: Sleep Disturbance and the Vicious Cycle of Chronic Stress. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 12; 4(12):1018-1020.
Score: 0.176
-
Apolipoprotein E gene polymorphism, posttraumatic stress disorder, and cognitive function in older U.S. veterans: Results from the National Health and Resilience in Veterans Study. Depress Anxiety. 2019 09; 36(9):834-845.
Score: 0.172
-
Salience Network Disruption in U.S. Army Soldiers With Posttraumatic Stress Disorder. Chronic Stress (Thousand Oaks). 2019 Jan-Dec; 3.
Score: 0.169
-
Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial. Contemp Clin Trials. 2019 06; 81:11-18.
Score: 0.168
-
Reduced Salience and Enhanced Central Executive Connectivity Following PTSD Treatment. Chronic Stress (Thousand Oaks). 2019 Jan-Feb; 3.
Score: 0.168
-
Neurobiological studies of trauma-related psychopathology: a public health perspective. Eur J Psychotraumatol. 2018; 9(1):1556554.
Score: 0.165
-
Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients. Chronic Stress (Thousand Oaks). 2018 Jan-Dec; 2.
Score: 0.162
-
The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder. Annu Rev Pharmacol Toxicol. 2019 01 06; 59:171-189.
Score: 0.162
-
Topology of brain functional connectivity networks in posttraumatic stress disorder. Data Brief. 2018 Oct; 20:1658-1675.
Score: 0.162
-
Altered White Matter Diffusivity of the Cingulum Angular Bundle in Posttraumatic Stress Disorder. Mol Neuropsychiatry. 2018 Oct; 4(2):75-82.
Score: 0.160
-
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology. 2018 09; 43(10):2154-2160.
Score: 0.159
-
Default mode network abnormalities in posttraumatic stress disorder: A novel network-restricted topology approach. Neuroimage. 2018 08 01; 176:489-498.
Score: 0.158
-
Stress Response Modulation Underlying the Psychobiology of Resilience. Curr Psychiatry Rep. 2018 03 28; 20(4):27.
Score: 0.157
-
Posttraumatic Stress Disorder and Depression Symptom Severities Are Differentially Associated With Hippocampal Subfield Volume Loss in Combat Veterans. Chronic Stress (Thousand Oaks). 2017 Jan-Dec; 1.
Score: 0.154
-
Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Oct; 2(7):566-574.
Score: 0.151
-
Combat Exposure Severity is Associated with Reduced Cortical Thickness in Combat Veterans: A Preliminary Report. Chronic Stress (Thousand Oaks). 2017 Jan; 1.
Score: 0.150
-
The Association of PTSD Symptom Severity with Localized Hippocampus and Amygdala Abnormalities. Chronic Stress (Thousand Oaks). 2017 Feb; 1.
Score: 0.150
-
Cortical thickness reduction in combat exposed U.S. veterans with and without PTSD. Eur Neuropsychopharmacol. 2017 05; 27(5):515-525.
Score: 0.146
-
A New Journal: Addressing the Behavioral and Biological Effects of Chronic Stress. Chronic Stress (Thousand Oaks). 2017 Jan-Dec; 1:2470547016683296.
Score: 0.145
-
Ketamine Treatment and Global Brain Connectivity in Major Depression. Neuropsychopharmacology. 2017 May; 42(6):1210-1219.
Score: 0.141
-
Glutamate and norepinephrine interaction: Relevance to higher cognitive operations and psychopathology. Behav Brain Sci. 2016 Jan; 39:e201.
Score: 0.134
-
Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Ann N Y Acad Sci. 2015 May; 1344:66-77.
Score: 0.127
-
Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression. NMR Biomed. 2024 Nov; 37(11):e5220.
Score: 0.061
-
STRONG STAR and the Consortium to Alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations. Contemp Clin Trials. 2021 11; 110:106583.
Score: 0.050
-
Locus Coeruleus Hyperactivity in Posttraumatic Stress Disorder: Answers and Questions. Biol Psychiatry. 2018 02 01; 83(3):197-199.
Score: 0.039
-
Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder. Hum Brain Mapp. 2016 09; 37(9):3214-23.
Score: 0.034
-
Amygdala-hippocampal volume and the phenotypic heterogeneity of posttraumatic stress disorder: a cross-sectional study. JAMA Psychiatry. 2015 Apr; 72(4):396-8.
Score: 0.032